Clinical Trials Browser

Phase 3 × INDUSTRY × irinotecan sucrosofate × Clear all

NCT04083235 2026-03-09

NAPOLI 3

Phase 3 Completed

770 enrolled 13 charts 1 FDA

Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas

NCT06625320 2025-12-12

RASolute 302

Phase 3 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03088813 2025-02-19

RESILIENT

Phase 3 Completed

491 enrolled 24 charts

Small Cell Lung Carcinoma

NCT03665441 2022-10-18

Trybeca-1

Phase 3 Completed

512 enrolled 19 charts

Neoplasms

NCT01494506 2016-06-17

NAPOLI-1

Phase 3 Completed

417 enrolled 20 charts

Gastrointestinal

Pancreatic Neoplasms